The overall theme of our research is the realization of “bench to bedside” via developing quantifiable imaging-based biomarkers which can be used for more accurate diagnosis as well as an outcome measurement for novel therapies. We are also interested in the therapeutic use of non-invasive brain stimulation techniques such as transcranial direct current stimulation, which has a potential clinical application to drug - refractory symptoms.